v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities    
Net loss $ (193,237) $ (194,632)
Adjustments to reconcile net loss to net cash used in operating activities:    
Allowance for expected credit losses 1,025 2,072
Depreciation and amortization 12,730 10,407
Amortization of deferred contract acquisition costs 19,189 15,971
Stock-based compensation expense 160,702 150,569
Net accretion of discount on marketable securities (4,646) (1,568)
Non-cash lease expense 13,528 13,998
Impairment of long-lived assets 0 5,009
Amortization of discount on revolving credit facility and term loan issuance costs 91 91
Changes in operating assets and liabilities:    
Accounts receivable 20,610 12,251
Prepaid expenses and other current assets (15,852) (13,764)
Other assets (4,594) 742
Accounts payable 4,610 3,612
Accrued expenses and other liabilities (11,408) (16,885)
Deferred revenue 10,920 21,843
Operating lease liabilities (14,598) (12,310)
Net cash used in operating activities (930) (2,594)
Cash flows from investing activities    
Purchases of marketable securities (166,628) (284,312)
Sales of marketable securities 0 12
Maturities of marketable securities 195,605 25,641
Purchases of property and equipment (4,064) (7,221)
Capitalized internal-use software costs (4,702) (4,325)
Net cash provided by (used in) investing activities 20,211 (270,205)
Cash flows from financing activities    
Repayment of term loan (1,875) (2,500)
Repurchases of common stock (73,869) 0
Proceeds from exercise of stock options 3,884 3,856
Proceeds from employee stock purchase plan 13,665 15,069
Taxes paid related to net share settlement of equity awards (5) (7)
Net cash provided by (used in) financing activities (58,200) 16,418
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (656) (1,868)
Net decrease in cash, cash equivalents, and restricted cash (39,575) (258,249)
Cash, cash equivalents, and restricted cash    
Beginning of period 236,663 526,563
End of period 197,088 268,314
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 196,772 268,314
Restricted cash 316 0
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows 197,088 268,314
Supplemental cash flow data    
Cash paid for income taxes 3,776 3,101
Supplemental non-cash investing and financing information    
Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities 1,193 286
Stock-based compensation expense capitalized for software development 3,299 3,034
Repurchases of common stock in accrued expenses and other current liabilities $ 820 $ 0